search
Back to results

Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy (DONTBIOPCE)

Primary Purpose

Barrett Syndrome, Barrett's Syndrome, Barrett's Esophagus

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Imaging procedures (NBI)
HDWLE
pCLE
Sponsored by
Mauna Kea Technologies
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Barrett Syndrome focused on measuring Barrett's Esophagus, EsoGastroDuodenoscopy, Barrett's Carcinoma, adenocarcinoma, Cellvizio, endomicroscopy, random biopsy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients with documented or suspected Barrett's esophagus presenting for endoscopy
  2. Age > 18 years
  3. Ability to provide written, informed consent

Exclusion Criteria:

  1. Presence of erosive esophagitis
  2. Inability to obtain biopsies due to anticoagulation, varices, etc.
  3. Allergy to fluorescein, pregnancy
  4. Presence of an esophageal mass other than small 10mm or less nodules
  5. Renal insufficiency

Sites / Locations

  • Mayo Clinic
  • Veterans Affairs Hospital
  • New York Presbyterian Hospital/Columbia University Medical Center
  • Centre Hospitalier Universitaire
  • Klinikum rechts der Isar

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Imaging Procedures HDWLE first NBI second and pCLE

Imaging Procedures NBI first HDWLE second and pCLE

Arm Description

All patients undergo both endoscopic imaging procedures and then the endomicroscopy procedure; the endoscopic imaging procedures being performed back to back by two endoscopists, blinded to each other.

All patients undergo both endoscopic imaging procedures and then the endomicroscopy procedure; the endoscopic imaging procedures being performed back to back by two endoscopists, blinded to each other.

Outcomes

Primary Outcome Measures

Comparative Histopathology-confirmed Measures of Per Lesion Sensitivity and Per Lesion Specificity, by Using pCLE Associated With WLE, or WLE Alone, for the Detection of High Grade Dysplasia and Early Carcinoma in Barrett's Esophagus.
Comparative Histopathology-confirmed Measures of Per Lesion Sensitivity and Per Lesion Specificity, by Using Probe-based Confocal Laser Endomicroscopy (pCLE) Associated With White Light Endoscopy (WLE), or WLE Alone, for the Detection of High Grade Dysplasia and Early Carcinoma in Barrett's Esophagus.

Secondary Outcome Measures

Full Information

First Posted
November 20, 2008
Last Updated
May 2, 2016
Sponsor
Mauna Kea Technologies
Collaborators
Cellvizio Inc., Emissary International LLC
search

1. Study Identification

Unique Protocol Identification Number
NCT00795184
Brief Title
Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy
Acronym
DONTBIOPCE
Official Title
Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy
Study Type
Interventional

2. Study Status

Record Verification Date
May 2016
Overall Recruitment Status
Completed
Study Start Date
November 2008 (undefined)
Primary Completion Date
September 2009 (Actual)
Study Completion Date
February 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mauna Kea Technologies
Collaborators
Cellvizio Inc., Emissary International LLC

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will collect data from patients routinely undergoing a endoscopic surveillance and Cellvizio endomicroscopy procedure due to confirmed Barrett's esophagus. The objective is to determine if endomicroscopy images collected using the marketed Cellvizio device may help endoscopists more accurately diagnose, in conjunction with traditional tissue sampling techniques, whether a suspected lesion is malignant or benign.
Detailed Description
This is a longitudinal observational study were imaging procedures are allocated in a random order to directly address the low sensitivity and specificity of enhanced macroscopic endoscopic imaging devices by determining whether probe-based Confocal Laser Endomicroscopy (pCLE), as a supplement to Narrow Band Imaging (NBI) can further improve sensitivity and specificity to a level that would be acceptable to avoid random biopsy, and better direct biopsy of suspicious areas. The study is also addressing pCLE as a supplement to standard white light endoscopy and random biopsy alone. In fact, the study is powered to evaluate per lesion sensitivity and specificity of confocal imaging as applied to lesions identified by white light endoscopy. Therefore, the study addresses the shortcomings of standard white light endoscopy (high number of random biopsies, less than ideal directed biopsy of suspicious areas) and the primary shortcomings of Narrow Band Imaging (NBI) (low specificity with resultant high false positives, again resulting in many unnecessary biopsies).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Barrett Syndrome, Barrett's Syndrome, Barrett's Esophagus, Barrett Esophagus, Adenocarcinoma
Keywords
Barrett's Esophagus, EsoGastroDuodenoscopy, Barrett's Carcinoma, adenocarcinoma, Cellvizio, endomicroscopy, random biopsy

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
122 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Imaging Procedures HDWLE first NBI second and pCLE
Arm Type
Other
Arm Description
All patients undergo both endoscopic imaging procedures and then the endomicroscopy procedure; the endoscopic imaging procedures being performed back to back by two endoscopists, blinded to each other.
Arm Title
Imaging Procedures NBI first HDWLE second and pCLE
Arm Type
Other
Arm Description
All patients undergo both endoscopic imaging procedures and then the endomicroscopy procedure; the endoscopic imaging procedures being performed back to back by two endoscopists, blinded to each other.
Intervention Type
Device
Intervention Name(s)
Imaging procedures (NBI)
Intervention Description
Imaging procedures (pCLE) and (NBI) - All patients undergo both procedures back to back by two endoscopists, blinded to each other, in randomized order. Procedure 1: Standard endoscopic procedure The patient receives white light endoscopy (WLE) examination. All visible lesions are noted and photographed. No biopsy is taken until both procedures are complete. Procedure 2: NBI endoscopic procedure The patient receives a NBI endoscopy examination. All visible and NBI abnormal lesions are noted and photographed. After both procedures are complete and all sites are unblinded to both endoscopists. pCLE with Cellvizio and physical biopsies are performed at all sites plus 4 quadrant sites.
Intervention Type
Device
Intervention Name(s)
HDWLE
Intervention Type
Device
Intervention Name(s)
pCLE
Other Intervention Name(s)
Cellvizio
Primary Outcome Measure Information:
Title
Comparative Histopathology-confirmed Measures of Per Lesion Sensitivity and Per Lesion Specificity, by Using pCLE Associated With WLE, or WLE Alone, for the Detection of High Grade Dysplasia and Early Carcinoma in Barrett's Esophagus.
Description
Comparative Histopathology-confirmed Measures of Per Lesion Sensitivity and Per Lesion Specificity, by Using Probe-based Confocal Laser Endomicroscopy (pCLE) Associated With White Light Endoscopy (WLE), or WLE Alone, for the Detection of High Grade Dysplasia and Early Carcinoma in Barrett's Esophagus.
Time Frame
Centralized histopathology confirmation within 4-6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with documented or suspected Barrett's esophagus presenting for endoscopy Age > 18 years Ability to provide written, informed consent Exclusion Criteria: Presence of erosive esophagitis Inability to obtain biopsies due to anticoagulation, varices, etc. Allergy to fluorescein, pregnancy Presence of an esophageal mass other than small 10mm or less nodules Renal insufficiency
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Prateek Sharma, MD
Organizational Affiliation
Veterans Affairs Hospital, Kansas City
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32224
Country
United States
Facility Name
Veterans Affairs Hospital
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64128
Country
United States
Facility Name
New York Presbyterian Hospital/Columbia University Medical Center
City
New York
State/Province
New York
ZIP/Postal Code
10032
Country
United States
Facility Name
Centre Hospitalier Universitaire
City
Nantes
ZIP/Postal Code
44093 Cedex 1
Country
France
Facility Name
Klinikum rechts der Isar
City
Munich
State/Province
Bayern
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
21741642
Citation
Sharma P, Meining AR, Coron E, Lightdale CJ, Wolfsen HC, Bansal A, Bajbouj M, Galmiche JP, Abrams JA, Rastogi A, Gupta N, Michalek JE, Lauwers GY, Wallace MB. Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc. 2011 Sep;74(3):465-72. doi: 10.1016/j.gie.2011.04.004. Epub 2011 Jul 13.
Results Reference
result

Learn more about this trial

Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy

We'll reach out to this number within 24 hrs